Venus Concept (VERO) Stock Price, News & Analysis

Company Overview

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $2.65 to $2.76
• 50-Day Range: $2.73 to $5.94
• 52-Week Range: $2.33 to $17.49
• Volume: 10,530 shs
• Average Volume: 91,525 shs
• Market Capitalization: $1.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Venus Concept Stock Analysis - MarketRank™

Venus Concept scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Venus Concept.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Venus Concept is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Venus Concept is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Venus Concept has been sold short.

Short Interest Ratio / Days to Cover

Venus Concept has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Venus Concept has recently decreased by 99.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Venus Concept does not currently pay a dividend.

Dividend Growth

Venus Concept does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of Venus Concept has been sold short.

Short Interest Ratio / Days to Cover

Venus Concept has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Venus Concept has recently decreased by 99.18%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: N/A

News Sentiment

Venus Concept has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Venus Concept this week, compared to 1 article on an average week.

Search Interest

2 people have searched for VERO on MarketBeat in the last 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Venus Concept insiders have not sold or bought any company stock.

Percentage Held by Insiders

48.96% of the stock of Venus Concept is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.41% of the stock of Venus Concept is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VERO Stock Analysis - Frequently Asked Questions

How have VERO shares performed this year?

Venus Concept's stock was trading at $4.1415 at the start of the year. Since then, VERO shares have decreased by 34.0% and is now trading at $2.7340.
View the best growth stocks for 2025 here.

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) posted its quarterly earnings results on Monday, March, 27th. The company reported ($23.10) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($23.10). The company earned $24.29 million during the quarter.

When did Venus Concept's stock split?

Shares of Venus Concept reverse split before market open on Tuesday, March 4th 2025. The 1-11 reverse split was announced on Friday, February 14th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 3rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venus Concept investors own include Tesla (TSLA), Agenus (AGEN), Cisco Systems (CSCO), Taiwan Semiconductor Manufacturing (TSM), Intel (INTC), Pfizer (PFE) and

Company Calendar

• Last Earnings: 3/27/2023
• Today: 3/11/2025
• Next Earnings (Estimated): 4/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VERO
• CIK: 1409269
• Web: www.venusconcept.com
• Phone: (888) 907-0115
• Fax: N/A
• Employees: 410
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($88.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-37,250,000.00
• Net Margins: -74.62%
• Pretax Margin: -74.60%
• Return on Equity: N/A
• Return on Assets: -47.46%

Debt

• Debt-to-Equity Ratio: 2.83
• Current Ratio: 1.86
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $67.20 million
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.43) per share
• Price / Book: -1.11

Miscellaneous

• Outstanding Shares: 660,000
• Free Float: 3,703,000
• Market Cap: $1.78 million
• Optionable: Not Optionable
• Beta: 0.52